Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis

Blankstein et al. (Wed,) studied this question.

www.synapsesocial.com/papers/6a0b2de23a96fd342f4319bc — DOI: https://doi.org/10.1016/j.jacc.2013.09.022

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Are Implantable Cardioverter Defibrillator Shocks a Surrogate for Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy?· 2006 · 294 citations
2. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.· 1978 · 980 citations
3. Cardiac Sarcoidosis Masquerading as Right Ventricular Dysplasia· 2003 · 81 citations
4. The Use of ¹⁸F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience· 2012 · 509 citations
5. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis· 2013 · 298 citations